Key result
An elevated monocyte-to-high-density lipoprotein ratio was independently associated with a significantly increased risk of atrial fibrillation among patients with nonalcoholic fatty liver disease (OR 10.67).
Why the study?
Patients with NAFLD are at high risk of AF, potentially driven by inflammation and oxidative stress, but the biomarker MHR had not been studied in this population.
Is the monocyte-to-high-density lipoprotein ratio (MHR) associated with the occurrence of atrial fibrillation in patients with NAFLD?
Case-Control (n=817)
No
Is the monocyte-to-high-density lipoprotein ratio (MHR) associated with the occurrence of atrial fibrillation in patients with NAFLD?
Odds Ratio: 10.67 (95% CI 2.17–52.37)
p-value: p=0.004
The monocyte-to-high-density lipoprotein ratio is a novel, independent predictor of atrial fibrillation in patients with nonalcoholic fatty liver disease, particularly when the ratio exceeds 0.44.
MHR may aid AF risk stratification in NAFLD; leaves open causal role and requires prospective validation before practice change.
Background: Accumulating evidence suggests that patients with nonalcoholic fatty liver disease (NAFLD) have a significantly high risk of incident atrial fibrillation (AF). Systemic inflammation, metabolic disorders and oxidative stress could be the potential mechanisms by which NAFLD drives AF. Monocyte-to- high-density lipoprotein ratio (MHR) has emerged as a novel biomarker of inflammation and oxidative stress that has not been studied in AF with NAFLD patients. We aimed to investigate the relationship between MHR and the risk of AF among NAFLD patients. Methods: A retrospective analysis was performed for the clinical data of the patients with NAFLD in the Second Hospital of Shanxi Medical University from January 2019 to October 2022, among whom 204 patients with AF were enrolled as NAFLD+AF group and 613 patients without AF were enrolled as NAFLD control, and 152 patients were selected from each group based on propensity score matching (PSM) at a ratio of 1:1 to balance the covariates between groups. The t-test or the Mann-Whitney U test was used for comparison of continuous data between two groups; the chi-square test or the Fisher's exact test was used for comparison of categorical data between two groups. Logistic regression analysis was performed to identify the independent predictor for occurrence of AF among NAFLD patients. Trend chi-square test to analyze the prevalence of AF among MHR tertiles, and then the correlation between MHR and the risk of AF confirmed by restricted cubic splines (RCS). The receiver operating characteristic (ROC) curve analysis was used to determine the optimum MHR cutoff value to predict AF. Results: Univariate analysis showed that AF patients had higher MHR than non-AF patients (P < 0.001). Meanwhile, compared with pure NAFLD patients, multivariate logistic regression analysis showed that MHR remained to be an independent risk factor for AF after adjusting for confounding risk factors (OR = 10.67, 95% CI 2.17-52.37, P = 0.004). TC、HDL-C were also independent risk factors for AF. Among them, TC and HDL-C are protective factors for AF. The trend chi-square test showed that the risk of AF increased with an increase in MHR (P < 0.05). However, the RCS showed a nonlinear and J-shaped relationship between MHR and the risk of AF (P for non-linearity = 0.023). The occurrence of AF increased with increasing MHR only when MHR > 0.44. The ROC curve showed that MHR combined with traditional risk factors can improve the ability to predict AF. Conclusion: MHR is an independently associated with incident AF in patients with NAFLD and show a certain predictive value.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) conducted a case-control in Nonalcoholic fatty liver disease (NAFLD) (n=817). Monocyte-to-high-density lipoprotein ratio (MHR) vs. Lower MHR / NAFLD patients without atrial fibrillation was evaluated on Occurrence of atrial fibrillation (OR 10.67, 95% CI 2.17-52.37, p=0.004). An elevated monocyte-to-high-density lipoprotein ratio was independently associated with a significantly increased risk of atrial fibrillation among patients with nonalcoholic fatty liver disease (OR 10.67).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: